Mineralys Therapeutics, Inc. (MLYS)

Market Closed

16 Oct, 08:00 PM

NASDAQ (NGS)

20. 30

-1.34

-6.1922%

2.06B Market Cap

- P/E Ratio

- Div Yield

1.18M Volume

-2.58 Eps

$ 21.64

Previous Close

Investors:

+28

Add Transaction

Day Range

20.12 21.6

Year Range

20.12 47.65

Want to track MLYS and more in your Portfolio? 🎯

Get Started For Free

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc. - MLYS

NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mineralys Therapeutics, Inc. ("Mineralys" or the "Company") (NASDAQ:MLYS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Accesswire | 2 years ago

Mineralys Therapeutics, Inc. (MLYS) Q2 2024 Earnings Call Transcript

Mineralys Therapeutics, Inc. (NASDAQ:MLYS ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Dan Ferry - LifeSci Advisors Jon Congleton - Chief Executive Officer Adam Levy - Chief Financial Officer David Rodman - Chief Medical Officer Conference Call Participants Michael DiFiore - Evercore Richard Law - Goldman Sachs Annabel Samimy - Stifel Mohit Bansal - Wells Fargo Rami Katkhuda - LifeSci Capital Operator Welcome to the Mineralys Therapeutics Second Quarter 2024 Conference Call. At this time all lines are in a listen-only mode.

Seekingalpha | 2 years ago

Blog Affiliate Program Dividend Tracker About Terms Privacy Help Contact Us